These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34445285)

  • 21. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.
    Isaji T; Gu J; Nishiuchi R; Zhao Y; Takahashi M; Miyoshi E; Honke K; Sekiguchi K; Taniguchi N
    J Biol Chem; 2004 May; 279(19):19747-54. PubMed ID: 14998999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
    Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
    Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bisecting GlcNAc in cell growth control and tumor progression.
    Miwa HE; Song Y; Alvarez R; Cummings RD; Stanley P
    Glycoconj J; 2012 Dec; 29(8-9):609-18. PubMed ID: 22476631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease.
    Akasaka-Manya K; Manya H; Sakurai Y; Wojczyk BS; Kozutsumi Y; Saito Y; Taniguchi N; Murayama S; Spitalnik SL; Endo T
    Glycobiology; 2010 Jan; 20(1):99-106. PubMed ID: 19776078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
    Dan W; Li C; Li J; Li P; Xin M; Chen Z; Dang L; Yu Z; Li J; Shen J; Hu L; Sun S
    Glycoconj J; 2022 Dec; 39(6):737-745. PubMed ID: 36322335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells.
    Shigeta M; Shibukawa Y; Ihara H; Miyoshi E; Taniguchi N; Gu J
    Glycobiology; 2006 Jun; 16(6):564-71. PubMed ID: 16531477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
    Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
    Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
    Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
    FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate specificities and intracellular distributions of three N-glycan processing enzymes functioning at a key branch point in the insect N-glycosylation pathway.
    Geisler C; Jarvis DL
    J Biol Chem; 2012 Mar; 287(10):7084-97. PubMed ID: 22238347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
    Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
    Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
    Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
    Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the GlcNAc(beta)1,2Man(alpha)- moiety in mammalian development. Null mutations of the genes encoding UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2 cause embryonic lethality and congenital muscular dystrophy in mice and men, respectively.
    Schachter H
    Biochim Biophys Acta; 2002 Dec; 1573(3):292-300. PubMed ID: 12417411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bidirectional N-acetylglucosamine transfer mediated by beta-1,4-N-acetylglucosaminyltransferase III.
    Okada T; Ihara H; Ito R; Taniguchi N; Ikeda Y
    Glycobiology; 2009 Apr; 19(4):368-74. PubMed ID: 19095698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc.
    Koyota S; Ikeda Y; Miyagawa S; Ihara H; Koma M; Honke K; Shirakura R; Taniguchi N
    J Biol Chem; 2001 Aug; 276(35):32867-74. PubMed ID: 11443114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
    Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
    Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
    Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling.
    Cheng L; Cao L; Wu Y; Xie W; Li J; Guan F; Tan Z
    Front Oncol; 2020; 10():929. PubMed ID: 32612952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel carbohydrate binding activity of annexin V toward a bisecting N-acetylglucosamine.
    Gao-Uozumi CX; Uozumi N; Miyoshi E; Nagai K; Ikeda Y; Teshima T; Noda K; Shiba T; Honke K; Taniguchi N
    Glycobiology; 2000 Nov; 10(11):1209-16. PubMed ID: 11087713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions.
    Allam H; Aoki K; Benigno BB; McDonald JF; Mackintosh SG; Tiemeyer M; Abbott KL
    J Proteome Res; 2015 Jan; 14(1):434-46. PubMed ID: 25437919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.